Campaigning to redirect resources from drug control to harm reduction:

Slides:



Advertisements
Similar presentations
The 2013 Consolidated WHO Guidelines on ARV Use: Implementing to Achieve Maximum Impact Gottfried Hirnschall, MD, MPH Director, HIV/AIDS Department, WHO.
Advertisements

TUBERCULOSIS Tuberculosis (TB) is a contagious disease. If left untreated, it can be fatal. The largest number of TB cases in 2005 were in South-East Asia.
XIX International AIDS Conference Washington, DC - July 19, 2012 T. Bella Dinh-Zarr, PhD, MPH North American Director, Road Safety Fund Road Safety Director,
World AIDS Day 1 December Bringing attention to the global AIDS epidemic and the critical need for a committed, meaningful and sustained response.
CHILDHOOD INJURY PREVENTION CONFERENCE1. Child Pedestrian Injuries: A Global Problem Priti Gautam Thursday, June 20 2.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
Improving health and protecting human rights Improving health and protecting human rights for individuals, communities, and society Harm reduction and.
Regional Overview of Progress on Universal Access in Asia-Pacific Steve Kraus, Regional Director UNAIDS Regional Support Team for Asia and the Pacific.
AIDS IN ASIA – PRIORITIZING AND SUSTAINING THE RESPONSE IN THE ECONOMIC CRISIS Hanoi September 2009 ADB Consultant Ross McLeod.
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
STRATEGY OF DRUG AND HIV/AIDS PREVENTION IN THE CITY AND DISTRICTS OF TALLINN Ene Tomberg Department of Social Welfare and Health Care of Tallinn.
Securing the future today Synthesis of strategic information on HIV and young people Global Interagency Task Team on HIV and young people, June 2011.
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
The Global HIV/AIDS Epidemic Jennifer Kates, M.A., M.P.A. Vice President and Director, HIV Policy Kaiser Family Foundation KaiserEDU.org Tutorial April.
The Need for Early Action on AIDS in Asia and the Pacific Dr. Bertrand Desmoulins, UNICEF Representative in Mongolia UN Theme Group Chair December 2, 2008.
Scaling-up harm reduction services towards universal access in Asia Models of good practice ICAAP IX Bali, Indonesia Nai Zindagi, Pakistan.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Adolescents (10-19 yr) Last updated: November 2015.
HIV and AIDS Data Hub for Asia-Pacific 1 Review in slides Children, Young People and Women HIV and AIDS Data Hub for Asia-Pacific.
World Vision Experiences in Making ART Treatment Affordable and Available Dr. Daniel J Malleboyina M.B.B.S, MBA, MPH Regional Advisor HIV & AIDS- Asia.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
HIV and AIDS Data Hub for Asia-Pacific 1 Review in slides Women, Children, and Young People HIV and AIDS Data Hub for Asia-Pacific.
1 Socio Economic Impact of AIDS in Asia XVII International AIDS Conference Mexico City, Mexico August 5, 2008 Jacques Jeugmans Asian Development Bank presented.
Evidence-based strategic investment to sustain the HIV response Conference on Measuring and Achieving Universal Health Coverage (UHC) with Information.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
وضعیت HIV/AIDS در جهان و ايران
Perspectives from the MSM community in Asia on sexual pleasure and risk reduction 9th IAS Conference on HIV Science 25 July 2017 Paris, France Midnight,
Resource Availability for HIV, Overview of the financing situation
International Resource Availability for HIV, 2015
TB-HIV Last updated: January 2017.
Fabienne Hariga Senior Adviser, HIV/AIDS Section
27 years of responding to AIDS
deaths per year (2013 WHO estimates)
The global state of harm reduction funding
financial requirements
Needle and syringe exchange and working with injecting drug users
Harm reduction: decriminalising drug use in Asia
The Status of the epidemic in
27 years of responding to AIDS
Total Estimated Available Resources for HIV from All Sources
Nebojša Đurasović Vilnius, April 2017.
The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002–2014)  Jamie Bridge,
Global epidemiology of injecting drug use
Key Affected Populations
Adolescents (10-19 yr) Last updated: October 2017.
Edo Agustian Indonesian Drug Users Network
وضعیت HIV/AIDS در جهان ومنطقه مرکز مدیریت بیماری ها - اداره كنترل ایدز و بیماری های آمیزشی
People who inject drugs
TB-HIV Last updated: March 2018.
Harm Reduction at the Crossroads Drugs, drug policy, harm reduction: A reality check International AIDS Conference July 25, 2018 Amsterdam Daniel.
By: Dr Mirzaei.
"3 by 5" progress December 2005.
27 years of responding to AIDS
TB-HIV Last updated: November 2018.
10 by 20 campaign: Strategies for tracking and rebalancing investment in drug law enforcement and harm reduction Emily Rowe, Harm Reduction International.
Midnight Poonkasetwattana
Edward Mbizo Sibanda, (MSc) Right to Care
Adolescents (10-19 yr) Last updated: November 2018.
Financial and Work Plan FY 2018
Global Village Debate This house would ban information dissemination on safe injecting practices, and ban the provision of clean and sterile injecting.
Showing throughout the event
Update on HIV and TB situation in SEAR Dr Mukta Sharma RA HIV TB HEP WHO SEARO Global Fund , South-East Asia Constituency Meeting, April 2018,
Strategies for sustainable financing of harm reduction:
Indonesia Harm Reduction Funding Tracking
Financing South Africa’s HIV Response
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Goal 6: Combat HIV/AIDS, malaria and other diseases
Cumulative number of HIV infections
Presentation transcript:

Campaigning to redirect resources from drug control to harm reduction: A guide to launching 10 by 20 in your country Olga Szubert, Advocacy Manager, Harm Reduction International July 2018 I am presenting this on behalf of my colleague Olga, who was unable to attend the conference. www.hri.global

What is the campaign about? The 10by20 campaign is Harm Reduction International’s global campaign to increase national and international financial support for harm reduction. We are calling on governments: To redirect 10 per cent of the resources that they currently spend on the ineffective drug control to harm reduction by 2020. What I want to highlight here, the campaign ask is not literal.

The state of harm reduction Global coverage of harm reduction interventions to prevent HIV, HCV and overdose is critically low, with less than 1% of people who inject drugs living in countries with high coverage; Between 2011 and 2015 new HIV infections among people who inject drugs increased by one third; Fatal overdose deaths are on the rise globally; Funding for harm reduction in LMICs declined between 2007 and 2016.

How much money is spend on harm reduction?

Potential of the 10 by 20 campaign In many countries, spending on drug control exceeds investment in harm reduction – globally, governments spend at least $100 billion every year on drug control.

For more information, visit www.hri.global/10by20 Thank you! For more information, visit www.hri.global/10by20 Or email 10by20@hri.global #10by20 The Harm Reduction Investment Study is conducted in the frame of the “Harm Reduction Advocacy in Asia (HRAsia)” project (2017-2019). The project is funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria to enable access to HIV and harm reduction services for people who inject drugs in Cambodia, India, Indonesia, Nepal, Philippines, Thailand and Vietnam. The views described herein are the views of Harm Reduction International (HRI), and do not represent the views or opinions of the Global Fund to Fight AIDS, Tuberculosis and Malaria, nor is there any approval or authorization of this material, express or implied, by the Global Fund to Fight AIDS, Tuberculosis and Malaria. Also on the tables you will find the 10by20 briefs for you to read more.